Skip to content

Cohort study of carcinogenesis of hepatocellular carcinoma in chronic liver diseases

Cohort study of carcinogenesis of hepatocellular carcinoma in chronic liver diseases - Cohort study of carcinogenesis of hepatocellular carcinoma in chronic liver diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000026149
Enrollment
610
Registered
2017-02-16
Start date
2016-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with chronic liver diseases

Interventions

None listed

Sponsors

Yokohama City University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with chronic liver disease by interview, blood collection, imaging studies. 2. Patients who are provided a written informed consent, and do not meet the below exclusion criteria.

Exclusion criteria

Exclusion criteria: 1. MRI examination is impossible (ex. Installation of pacemaker, claustrophobia) 2. Pregnant patients 3. In the opinion of the investigator, patient is unsuitable as a study subject.

Design outcomes

Primary

MeasureTime frame
To elucidate the risk factor of carcinogenesis of HCC by assessing time-dependent change of liver pathogenesis by using MR elastography and transient elastgraphy.

Secondary

MeasureTime frame
To elucidate the risk factor of carcinogenesis of HCC by hematological examination and therapeutic situation of lifestyle-related diseases.

Countries

Japan

Contacts

Public ContactYuji Ogawa

Yokohama City University Graduate School of Medicine Department of Gastroenterology and Hepatology

ogaway@yokohama-cu.ac.jp045-787-2640

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026